U.S. public health officials are investigating a multi-state outbreak of explosive diarrhea caused by the Cyclospora parasite [1, 2].

The scale of the outbreak suggests a widespread contamination of the food or water supply. Because the source remains unidentified, thousands of people remain at risk of infection while officials race to prevent further cases.

The Centers for Disease Control and Prevention (CDC) and other health agencies are tracking the spread of the parasite across the country [1]. Reports on the geographic reach vary, with some data indicating the outbreak has touched 17 to 31 states [5, 6].

Case counts also show significant discrepancies across reporting agencies. Some reports list more than 1,400 cases [1], while other data suggests the number is nearly 7,000 [4]. A particularly large cluster has emerged in Michigan, where officials have recorded between 572 and 576 cases [3].

Investigators have not yet identified the specific food or water source that introduced the parasite to the population [2, 4]. The search for the origin has faced setbacks, including a false positive reported by the Food and Drug Administration (FDA) [2].

Cyclospora is a parasite that typically causes gastrointestinal distress. Public health officials continue to monitor new reports to pinpoint the contaminated product, a process that often requires tracing the dietary histories of hundreds of infected patients to find a common link.

The CDC has urged the public to take precautions to protect themselves as the investigation continues [5]. Until a specific product is recalled, officials remain focused on identifying the environmental or commercial source of the contamination [2].

The source of the infection remains unknown

The discrepancy in case numbers and affected states indicates a rapidly evolving situation or fragmented reporting during the early stages of the outbreak. The FDA's admission of a false positive suggests that identifying the source of Cyclospora is technically challenging, which may prolong the period of public risk before a targeted product recall can be implemented.